New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 9, 2014
09:13 EDTCOH, LXRX, SLXP, AVAV, RAI, AAL, CELG, GRMN, MSM, BOBE, GIMO, BP, KKR, SDRL, SIMG, LO, TCSOn The Fly: Pre-market Movers
HIGHER: American Airlines (AAL), up 5.5% after reporting its June traffic rose 1%, forecasting its 2014 total system capacity to be up 3% from last year... AeroVironment (AVAV), up 5.5% after reporting better than expected Q4 earnings results... Reynolds American (RAI), up 1.3% after Daily Mail reported that British American Tobacco (BTI) is rumored to be near a deal to buy out the stake in Reynolds it does not already own, which would prevent a Reynolds takeover of Lorillard (LO). Lorillard shares are down 1.4% in pre-market trade following the report... Lexicon (LXRX), up 11.5% after announcing JDRF, the world's largest non-profit supporter of type 1 diabetes research, will provide funding to support a Phase 2 trial to evaluate the efficacy and safety of LX4211... Seadrill (SDRL), up 3% after cancelling contemplated convertible bond issuance... KKR (KKR), up 1.3% after upgraded to Outperform at Credit Suisse. DOWN AFTER EARNINGS: Container Store (TCS), down 15%... Bob Evans (BOBE), down 1.2%... MSC Industrial (MSM), down 3%. ALSO LOWER: Gigamon (GIMO), down 32% following downgrades at five firms after the company lowered its Q2 revenue guidance... Garmin (GRMN), down 2.7% following downgrade at Pacific Crest... Silicon Image (SIMG), down 11% after cutting second quarter guidance... Salix (SLXP), down 4% after announcing deal to combine with Cosmo Technologies... Celgene (CELG), down 1.5% after OTEZLA did not achieve primary endpoint in Phase III trial... Coach (COH), down 0.7% following downgrade at Buckingham... BP (BP), down 1% after downgraded at Deutsche Bank.
News For AAL;TCS;GIMO;RAI;LO;BOBE;AVAV;SIMG;MSM;SLXP;SDRL;GRMN;LXRX;KKR;CELG;COH;BP From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | all recent news | >>
November 18, 2014
07:34 EDTCELGCelgene presents long-term OTEZLA data at ACR/ARHP meeting
Celgene announced that results from long-term efficacy and safety analyses of OTEZLA from the open-label phase of two PALACE phase III clinical trials were presented at the 2014 American College of Rheumatology/Association of Rheumatology Health Professionals annual meeting in Boston. OTEZLA is the Company’s oral, selective inhibitor of phosphodiesterase 4, approved by the U.S. FDA for the treatment of adult patients with active psoriatic arthritis and for the treatment of patients with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy. In PALACE 1, 84 percent of patients who completed one year of 30 mg twice daily therapy continued to receive OTEZLA at two years. Improvements in efficacy measures observed at 52 weeks were sustained through 104 weeks of treatment. At week 104, among patients receiving OTEZLA 30 mg twice daily, the ACR20 response rate was 65.3 percent. ACR50 and 70 response rates were 34.0 percent and 19.6 percent, respectively, at week 104. Similar findings were observed in PALACE 4. In this trial, nearly 84 percent of DMARD-naïve patients who completed one year of OTEZLA 30 mg twice daily monotherapy continued to receive OTEZLA at two years. At week 104, among patients treated with OTEZLA 30 mg twice daily monotherapy, an ACR20, 50 and 70 response was reached by 61.4 percent, 40.7 percent and 19.2 percent of patients, respectively. In both PALACE 1 and PALACE 4, changes in other efficacy measures—including the HAQ-DI, which assesses improvements in physical function, and swollen and tender joint counts—were also generally sustained between weeks 52 and 104 with continued OTEZLA treatment. In PALACE 4, treatment with OTEZLA in patients with pre-existing enthesitis or dactylitis, two key manifestations of psoriatic arthritis, resulted in improvements in enthesitis and dactylitis that were sustained through 104 weeks of treatment.
06:30 EDTRAIReynolds American to launch new cigarette that only heats tobacco, WSJ reports
Subscribe for More Information
November 17, 2014
16:31 EDTMSMMSC Industrial CFO Jeff Kaczka to retire
Subscribe for More Information
11:15 EDTBPBP to invest $200M to upgrade U.S., Belgian petrochemical plants
BP announced that it plans to invest over $200M to upgrade its purified terephthalic acid plants at Cooper River, South Carolina and Geel, Belgium. The investments will position these assets amongst the most efficient PTA manufacturing facilities in the world. Reference Link
08:56 EDTGIMOGigamon management to meet with Needham
Subscribe for More Information
07:16 EDTCELGMilken Institute--Faster Cures to hold a conference
Subscribe for More Information
November 14, 2014
17:13 EDTAAL, LOAppaloosa gives quarterly update on stakes
NEW STAKES: NXP Semiconductors (NXPI), Lorillard (LO), Alibaba (BABA), and Shire (SHPG). INCREASED STAKES: Whirlpool (WHR), Priceline (PCLN), Delta (DAL), CBS (CBS), and General Motors (GM). DECREASED STAKES: American Airlines (AAL), Disney (DIS), Apple (AAPL), MGM Resorts (MGM), and Eastman Chemical (EMN). LIQUIDATED STAKES: Expedia (EXPE), AIG (AIG), Prudential (PRU), Celanese (CE), and ASML Holding (ASML).
17:07 EDTCELG, AALSoros Fund Management gives quarterly update on stakes
Subscribe for More Information
16:52 EDTBPGreenlight Capital gives quarterly update on stakes
Subscribe for More Information
12:41 EDTMSMMSC Industrial management to meet with Jefferies
Meeting to be held in Boston on November 19 hosted by Jefferies.
10:00 EDTTCSOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: AbbVie (ABBV) initiated with a Buy at Deutsche Bank... Advance Auto Parts (AAP) initiated with a Buy at Sterne Agee... AutoZone (AZO) initiated with an Underperform at Sterne Agee... Carter's (CRI) initiated with a Buy at Sterne Agee... Children's Place (PLCE) initiated with a Neutral at Sterne Agee... Container Store (TCS) initiated with a Fair Value at CRT Capital... DHT Holdings (DHT) initiated with a Buy at UBS... Diana Shipping (DSX) initiated with a Neutral at UBS... Genuine Parts (GPC) initiated with a Neutral at Sterne Agee... National Oilwell (NOV) initiated with a Neutral at UBS... Navios Acquisition (NNA) initiated with a Buy at UBS... NeoStem (NBS) assumed with a Buy at Maxim... O'Reilly Automotive (ORLY) initiated with a Neutral at Sterne Agee... Scorpio Bulkers (SALT) initiated with a Neutral at UBS... Star Bulk Carriers (SBLK) initiated with a Neutral at UBS... Teekay Tankers (TNK) initiated with a Buy at UBS... The Buckle (BKE) initiated with an Underweight at BB&T... TriMas (TRS) initiated with an Overweight at JPMorgan... TriplePoint Venture (TPVG) initiated with a Buy at UBS... Tsakos Energy (TNP) initiated with a Buy at UBS... USD Partners (USDP) initiated with an Outperform at Credit Suisse... Zumiez (ZUMZ) initiated with a Buy at BB&T.
10:00 EDTSLXPOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
07:14 EDTCELGAmerican College of Rheumatology is holding a meeting
2014 ACR/ARHP Annual Meeting is being held in Boston on November 14-19.
06:03 EDTSLXPSalix upgraded to Buy from Neutral at UBS
UBS upgraded Salix Pharmaceuticals to Buy saying it believes management has a better handle on inventory levels than investors think. The sees opportunity at current share levels and lowered its price target for shares to $116 from $160.
05:58 EDTBPLawsuit accuses BP of overcharging California agencies for natural gas, AP says
Subscribe for More Information
05:29 EDTTCSContainer Store initiated with a Fair Value at CRT Capital
Subscribe for More Information
November 13, 2014
17:06 EDTBPBP loses bid for new trial regarding negligence in oil spill, Bloomberg says
Subscribe for More Information
14:50 EDTAALLonestar Capital to shut down by mid-2015, WSJ reports
Subscribe for More Information
14:45 EDTAALLonestar capital to shut down, DJ reports
Subscribe for More Information
11:35 EDTRAIReynolds American to host investor day
Subscribe for More Information
1 | 2 | 3 | 4 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use